Table:
begin	end	state
1	25	signal peptide
26	39	non-cytoplasmic
40	60	transmembrane
61	91	cytoplasmic
92	108	transmembrane
109	115	non-cytoplasmic
116	134	transmembrane
135	139	cytoplasmic
140	158	transmembrane
159	163	non-cytoplasmic
164	186	transmembrane
187	194	cytoplasmic
195	211	transmembrane
212	262	non-cytoplasmic
263	283	transmembrane
284	310	cytoplasmic
311	333	transmembrane
334	348	non-cytoplasmic
349	376	transmembrane
377	387	cytoplasmic
388	405	transmembrane
406	418	non-cytoplasmic

Input:
>Pf6N2E2_2924
MTRHLKSALFSALLVWAVAYPVLGLKLTIVGINLEVHGTSPAILATIAVCSLLMFLRVLF
STQISAMWKSSPGLPVIPAKASNFLTLPTTQRWIVLALIVGALVWPFFGSRGAVDIATLI
LIYVMLGLGLNIVVGLAGLLDLGYVGFYAVGAYSYALLSHYFGLSFWICLPIAGMMAATF
GFLLGFPVLRLRGDYLAIVTLGFGEIIRLFLRNLTDITGGPNGISNIEKPTFFGLTFERK
AAEGLQTFHEYFGLEYNSINKVIFLYLVALLLALAALFVINRLLRMPIGRAWEALREDEI
ACRALGLNPTVIKLSAFTLGAAFAGFAGSFFAARQGLVTPESFTFIESAIILAIVVLGGM
GSQLGVILAAIVMILLPEMMREFSEYRMLMFGALMVLMMIWRPQGLLPMQRPHMELRK

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server